Neoadjuvant chemoradiation for non ‐metastatic pancreatic cancer increases margin‐negative and node‐negative rates at resection

CONCLUSIONSNeoadjuvant chemoradiation remains a promising approach for non‐metastatic pancreatic cancer for improving resectability and pathological and clinical findings. Computed tomography may not fully demonstrate the effectiveness of neoadjuvant treatment.
Source: Journal of Digestive Diseases - Category: Gastroenterology Authors: Tags: Original Article Source Type: research